Arthritis Clinical Trials 2024

Arthritis Clinical Trials 2024

Arthritis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in arthritis clinical trials today.

Arthritis Clinical Trials

Here are the 6 most popular medical studies for arthritis

Popular filter options for arthritis trials

Osteoarthritis Clinical Trials

View 45 Osteoarthritis medical studies.

Rheumatoid Arthritis Clinical Trials

View 42 Rheumatoid Arthritis medical studies.

Phase 3 Arthritis Clinical Trials

View 92 phase 3 arthritis medical studies.

Arthritis Clinical Trials With No Placebo

View 92 arthritis medical studies that do not have a placebo group.

View More Arthritis Trials

See another 73 medical studies focused on arthritis.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to arthritis

What are the top hospitals conducting arthritis research?

When it comes to advancing our understanding and treatment of arthritis, several top hospitals are leading the way with their dedication to clinical trials. The Altoona Center for Clinical Research in Duncansville has made significant strides in this field, currently conducting six active arthritis trials while having completed a total of 30 trials since recording their first study in 2005. Located in Palm Desert, Desert Medical Advances is another institution making a notable impact on arthritis research, currently engaged in four ongoing trials and boasting an impressive history of 39 completed studies dating back to 2005.

Meanwhile, Health Research of Oklahoma situated in Oklahoma City has also emerged as a key player by contributing valuable insights through its four active arthritis trials and successful completion of 25 previous investigations since starting its pioneering trial series much later than others -in2008. Another renowned facility dedicated to improving the lives of those with arthritis is Brigham and Women's Hospital located right at Boston which stands equally strong concerning actively participating clinical tests(4)and having previously accomplished two dozen such experiments beginning from year2002.

Lastly yet significantly,the Hospital for Special Surgery based out New york brings its own expertise into play with four current arthritis clinical trials and completing nineteen such research endeavors until now that trace all way back upto1999.Oftentimes dubbed as "the best hospital for orthopedics" globally,this particular institute certainly exemplifies how their work extends beyond just bones but helps improve overall health outcomes too.

These hospitals serve as beacons of hope for individuals living with the challenges presented by arthritis. Their commitment to pushing boundaries through rigorous scientific investigation not only enhances our knowledge but also paves the way for innovative therapies that can alleviate pain and improve quality of life for millions around the world affected by this condition

Which are the best cities for arthritis clinical trials?

When it comes to arthritis clinical trials, several cities emerge as top contenders in research and development. Houston, Texas takes the lead with 30 active trials focusing on treatments like Upadacitinib, Baricitinib, and Lorecivivint. Chicago, Illinois follows closely behind with 26 ongoing studies examining innovative approaches such as Upadacitinib, Tofacitinib, and Certolizumab Pegol (CZP). Phoenix, Arizona and Tampa, Florida both offer promising opportunities for participants with 23 active trials each that explore treatments like Upadacitinib, Guselkumab, Peresolimab, and Risankizumab. Finally Duncansville in Pennsylvania provides access to 18 active trials investigating potential breakthroughs including Upadacitinib and Risankizumab. These cities serve as hubs for cutting-edge arthritis clinical trials that pave the way for advancements in treatment options for individuals living with this condition.

Which are the top treatments for arthritis being explored in clinical trials?

Arthritis research is driving innovation in the search for effective treatments. Upadacitinib, with its five active trials and 19 all-time arthritis trials since 2014, stands out as a top contender. Guselkumab follows closely behind with three current trials and an impressive track record of 12 previous arthritis studies since its listing in 2013. Also gaining attention is risankizumab, currently being explored in two ongoing trials after making its debut on the scene in 2019. And let's not forget about baricitinib, which has been involved in two active trials and a total of 16 arthritis studies since it was first listed back in 2007. These advancements hold promise for patients seeking relief from this chronic condition that affects millions around the world.

What are the most recent clinical trials for arthritis?

Recent clinical trials have opened up new possibilities for individuals suffering from arthritis. The Celltex-AdMSCs trial, currently in Phase 2, offers hope by exploring the potential of adipose-derived mesenchymal stem cells as a treatment option. Another promising study is investigating the effectiveness of ASA (acetylsalicylic acid) in Phase 3 trials, aiming to provide relief and improved management for arthritis patients. Additionally, GNSC-001's low dose formulation is being examined in Phase 1 trials to evaluate its safety and efficacy. The SAM Ultrasound Device and Diclofenac Patch trial has also shown promise in providing targeted pain relief for arthritis sufferers through innovative techniques. Lastly, Enhanced Implementation (EI), currently undergoing Phase 2 testing, aims to optimize existing treatments and improve outcomes for those living with arthritis. These ongoing studies bring renewed optimism to those affected by this debilitating condition.

What arthritis clinical trials were recently completed?

Several noteworthy clinical trials investigating potential treatments for arthritis have recently concluded, demonstrating the ongoing commitment to finding effective therapies for this debilitating condition. In January 2022, Takeda completed a trial evaluating NDI-034858's efficacy in managing arthritis symptoms. Another significant milestone occurred in October 2021 when Janssen Research & Development wrapped up two separate trials: one testing JNJ-67484703 and another exploring the potential of Nipocalimab. Additionally, UCB Biopharma SRL successfully completed a trial studying Certolizumab pegol back in February 2021. These recent advancements showcase the collective efforts of pharmaceutical companies and researchers in their quest to improve treatment options for individuals living with arthritis.